Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 121

1.

Cyclosporine a 0.05% eye drops for the treatment of subepithelial infiltrates after epidemic keratoconjunctivitis.

Okumus S, Coskun E, Tatar MG, Kaydu E, Yayuspayi R, Comez A, Erbagci I, Gurler B.

BMC Ophthalmol. 2012 Aug 18;12:42. doi: 10.1186/1471-2415-12-42.

PMID:
22900547
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Topical treatment with 1% cyclosporine for subepithelial infiltrates secondary to adenoviral keratoconjunctivitis.

Levinger E, Slomovic A, Sansanayudh W, Bahar I, Slomovic AR.

Cornea. 2010 Jun;29(6):638-40. doi: 10.1097/ICO.0b013e3181c33034.

PMID:
20458220
[PubMed - indexed for MEDLINE]
3.

Cyclosporine A 1% eye drops for the treatment of subepithelial infiltrates after adenoviral keratoconjunctivitis.

Jeng BH, Holsclaw DS.

Cornea. 2011 Sep;30(9):958-61. doi: 10.1097/ICO.0b013e31820cd607.

PMID:
21673568
[PubMed - indexed for MEDLINE]
4.

[Local cyclosporin A therapy of nummuli after epidemic keratoconjunctivitis--case report].

Reinhard T, Sundmacher R.

Klin Monbl Augenheilkd. 1997 Mar;210(3):165-8. German.

PMID:
9206749
[PubMed - indexed for MEDLINE]
5.

Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study.

Hillenkamp J, Reinhard T, Ross RS, Böhringer D, Cartsburg O, Roggendorf M, De Clercq E, Godehardt E, Sundmacher R.

Arch Ophthalmol. 2001 Oct;119(10):1487-91.

PMID:
11594949
[PubMed - indexed for MEDLINE]
6.

Topical 0.03% tacrolimus for subepithelial infiltrates secondary to adenoviral keratoconjunctivitis.

Levinger E, Trivizki O, Shachar Y, Levinger S, Verssano D.

Graefes Arch Clin Exp Ophthalmol. 2014 May;252(5):811-6. doi: 10.1007/s00417-014-2611-9. Epub 2014 Apr 4.

PMID:
24696044
[PubMed - in process]
7.

Topical cyclosporine a in the treatment of superior limbic keratoconjunctivitis: a long-term follow-up.

Sahin A, Bozkurt B, Irkec M.

Cornea. 2008 Feb;27(2):193-5. doi: 10.1097/ICO.0b013e318033bd25.

PMID:
18216575
[PubMed - indexed for MEDLINE]
8.

The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study.

Hillenkamp J, Reinhard T, Ross RS, Böhringer D, Cartsburg O, Roggendorf M, De Clercq E, Godehardt E, Sundmacher R.

Ophthalmology. 2002 May;109(5):845-50.

PMID:
11986086
[PubMed - indexed for MEDLINE]
9.

Topical cyclosporine A inhibits subepithelial immune infiltrates but also promotes viral shedding in experimental adenovirus models.

Romanowski EG, Pless P, Yates KA, Gordon YJ.

Cornea. 2005 Jan;24(1):86-91.

PMID:
15604872
[PubMed - indexed for MEDLINE]
10.

Topical cyclosporine A in severe steroid-dependent childhood phlyctenular keratoconjunctivitis.

Doan S, Gabison E, Gatinel D, Duong MH, Abitbol O, Hoang-Xuan T.

Am J Ophthalmol. 2006 Jan;141(1):62-66.

PMID:
16386977
[PubMed - indexed for MEDLINE]
11.

Outcome of treatment of mooren ulcer with topical cyclosporine a 2%.

Tandon R, Chawla B, Verma K, Sharma N, Titiyal JS.

Cornea. 2008 Sep;27(8):859-61. doi: 10.1097/ICO.0b013e3181702d0c.

PMID:
18724142
[PubMed - indexed for MEDLINE]
12.

Topical cyclosporine for atopic keratoconjunctivitis.

González-López JJ, López-Alcalde J, Morcillo Laiz R, Fernández Buenaga R, Rebolleda Fernández G.

Cochrane Database Syst Rev. 2012 Sep 12;9:CD009078. doi: 10.1002/14651858.CD009078.pub2. Review.

PMID:
22972132
[PubMed - indexed for MEDLINE]
13.

[Local cyclosporin A in nummuli after keratoconjunctivitis epidemica. A pilot study].

Reinhard T, Godehardt E, Pfahl HG, Sundmacher R.

Ophthalmologe. 2000 Nov;97(11):764-8. German.

PMID:
11130165
[PubMed - indexed for MEDLINE]
14.

Long-term safety and efficacy of topical cyclosporine in 156 children with vernal keratoconjunctivitis.

Pucci N, Caputo R, Mori F, De Libero C, Di Grande L, Massai C, Bernardini R, Novembre E.

Int J Immunopathol Pharmacol. 2010 Jul-Sep;23(3):865-71.

PMID:
20943058
[PubMed - indexed for MEDLINE]
15.

Epidemic keratoconjunctivitis: the current situation and recommendations for prevention and treatment.

Meyer-Rüsenberg B, Loderstädt U, Richard G, Kaulfers PM, Gesser C.

Dtsch Arztebl Int. 2011 Jul;108(27):475-80. doi: 10.3238/arztebl.2011.0475. Epub 2011 Jul 8. Review.

PMID:
21814523
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

[Epidemic keratoconjunctivitis: treatment results during an epidemic].

Hutter H.

Klin Monbl Augenheilkd. 1990 Sep;197(3):214-7. German.

PMID:
1701507
[PubMed - indexed for MEDLINE]
17.

A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis.

Ebihara N, Ohashi Y, Uchio E, Okamoto S, Kumagai N, Shoji J, Takamura E, Nakagawa Y, Nanba K, Fukushima A, Fujishima H.

J Ocul Pharmacol Ther. 2009 Aug;25(4):365-72. doi: 10.1089/jop.2008.0103.

PMID:
19441889
[PubMed - indexed for MEDLINE]
18.

Photorefractive keratectomy for myopia in the setting of adenoviral subepithelial infiltrates.

Fite SW, Chodosh J.

Am J Ophthalmol. 1998 Dec;126(6):829-31.

PMID:
9860010
[PubMed - indexed for MEDLINE]
19.

Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years.

Barber LD, Pflugfelder SC, Tauber J, Foulks GN.

Ophthalmology. 2005 Oct;112(10):1790-4.

PMID:
16102833
[PubMed - indexed for MEDLINE]
20.

A randomized, placebo-controlled trial of topical cyclosporin A in steroid-dependent atopic keratoconjunctivitis.

Hingorani M, Moodaley L, Calder VL, Buckley RJ, Lightman S.

Ophthalmology. 1998 Sep;105(9):1715-20.

PMID:
9754182
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk